Sorbitol May Convert to Fructose, Posing Health Risks

Researchers at Washington University in St. Louis have identified a potential health concern associated with sorbitol, a widely used sugar substitute. Sorbitol, a sugar alcohol found in numerous sugar-free products such as candies, gums, and low-calorie foods, may not be as metabolically inert as previously assumed. The study, published in the journal Cell Metabolism, indicates that the human body, specifically the liver, can convert sorbitol into fructose. This metabolic conversion could lead to adverse health effects that are comparable to those linked to excessive consumption of fructose, a simple sugar known for its detrimental impact on metabolic health.

Fructose has been extensively studied and is associated with a range of metabolic dysfunctions, including increased fat accumulation in the liver, insulin resistance, elevated triglyceride levels, and impaired glucose metabolism. The new findings suggest that individuals consuming products containing sorbitol might inadvertently be exposing themselves to these same risks. The conversion process occurs within the liver, a central organ for carbohydrate metabolism. While sorbitol itself is poorly absorbed in the small intestine, allowing it to pass to the large intestine where it is fermented by bacteria, this new research highlights an alternative pathway where a significant portion can be absorbed and processed by the liver.

The implications of this discovery are substantial, given the pervasive use of sorbitol in the food industry as a bulking agent, humectant, and sweetener. It is often employed to reduce the caloric content of foods and to prevent sugar crystallization, making it a popular choice for diabetic-friendly and dietetic products. The researchers utilized a combination of human and mouse models, along with stable isotope tracing, to demonstrate the metabolic fate of sorbitol. They observed that after ingestion, sorbitol is absorbed and transported to the liver, where enzymes facilitate its transformation into fructose-6-phosphate, a precursor to fructose. This fructose-6-phosphate then enters the glycolytic pathway, contributing to the overall fructose load in the liver.

This research challenges the long-held belief that sorbitol is a metabolically neutral sugar substitute. The study's lead author, Dr. Jian-Ying Wang, a professor of medicine at Washington University School of Medicine in St. Louis, stated that their findings reveal a "hidden problem" with sorbitol. The team's experiments showed that when sorbitol was administered to mice, it led to increased fat deposition in the liver and elevated levels of triglycerides, mirroring the effects of fructose. Further analysis in human subjects confirmed that sorbitol contributes to the hepatic fructose pool. The study also noted that the extent of sorbitol conversion to fructose can vary among individuals, suggesting a personalized metabolic response. This discovery necessitates a re-evaluation of sorbitol's role in dietary recommendations and food product labeling, particularly for individuals managing metabolic health conditions.